USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the European Bipolar-disorder Therapeutics Market
Analysis of the European Bipolar-disorder Therapeutics Market
Improving New Drug Formulations and Strong Product Pipelines Expected to Restore Growth beyond 2013
RELEASE DATE
18-May-2012
18-May-2012
REGION
Europe
Europe
Research Code: M855-01-00-00-00
SKU: HC01978-EU-MR_07214
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01978-EU-MR_07214
Description
This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatment—atypical antipsychotics, mood stabilisers and anti-depressants—with a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.
Table of Contents
Summary of the European Bipolar-disorder Therapeutics Market
- Executive Summary
Introduction to the European Bipolar-disorder Therapeutics Market
- Research Scope and Objectives
- Bipolar-disorder Disease Segmentation
- Geographic Scope
Overview of the European Bipolar-disorder Therapeutics Market
- Market Overview
Introduction to Bipolar-disorder Disease
- Bipolar Disorder- Definition
- Signs and Symptoms
- Diagnosis
- Diagnostic Scales for Bipolar-disorder
- Risk Factors
Management of Bipolar Disorder - Drugs Used and Treatment Regimen
- Classification of Drugs
- Treatment of Acute Mania
- Treatment of Depression
- Treatment of Mixed Episodes and Maintenance Phase
- Psychological Intervention
Epidemiology of Bipolar Disorder in Europe
- Demographics by Country
- Prevalence of Mood Disorders in Europe
- Prevalence and Mortality Rates of Bipolar Disorder by Age and Gender
- Lifetime Prevalence of Co-morbidities with Bipolar Disorder
- Bipolar-disorder Treatment Statistics in Europe
Industry Challenges, Market Drives and Restraints of the European Bipolar-disorder Therapeutics Market
- Industry Challenges- Impact and Duration
- Market Drivers and Restraints
- Impact Mapping of Drivers and Restraints
Market Engineering Measurements and Revenue Forecasts
- Market Engineering Measurements
- Forecast Assumptions
- Total Bipolar-disorder Therapeutics Market Revenue Forecast
- Total Bipolar-disorder Therapeutics Market Revenue Forecast Discussion
- Bipolar-disorder Therapeutics Market Per Cent of Revenue by Country
Analysis of the Competitive Landscape of the European Bipolar-disorder Therapeutics Market
- Competitive Structure
- Competitive Analysis: Profiling of Selected Key Market Participants
- Competitive Analysis: Promising Companies in the Future
- Bipolar-disorder Therapeutics Market Competitive Landscape
Analysis of the Marketed Products for Bipolar Disorder
- Marketed Product Analysis — Bipolar-disorder Medication
- Marketed Product Analysis — Key Patent Expiries
Analysis of Potential Bipolar Drug Candidates in Pipeline
Cost Analysis of the European Bipolar-disorder Therapeutics Market
Regulatory Analysis of the European Bipolar-disorder Therapeutics Market
Analysis of the Atypical Antipsychotic Drugs Segment for Bipolar Disorder
Analysis of the Mood-stabilising Drugs Segment for Bipolar Disorder
Analysis of the Anti-depressant Drugs Segment for Bipolar Disorder
Germany Bipolar-disorder Therapeutics Market
France Bipolar-disorder Therapeutics Market
The United Kingdom Biolar-disorder Therapeutics Market
Italy Bipolar-disorder Therapeutics Market
Spain Bipolar-disorder Therapeutics Market
Conclusions and Implications
Summary of Major Findings of the European Bipolar-disorder Therapeutics Market
Support Databases
Popular Topics
This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatmentatypical antipsychotics, mood stabilisers and anti-depressantswith a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Aiswariya Chidambaram |
| Industries | Healthcare |
| WIP Number | M855-01-00-00-00 |
| Is Prebook | No |